Objective:To explore the effects of S100A9 knockout on mice with lupus nephritis(LN)induced by pristane,and clarify specific roles of S100A9 in LN. Methods:Ten female wild-type(WT)C57BL/6(B6)mice and ten S100A9-/- B6 mice(6-8 weeks old) were used. Five WT B6 mice and five S100A9-/- B6 mice were intraperitoneally injected with 0.5 mL pristane,respectively,serving as experimental groups. Other five WT B6 mice and five S100A9-/- B6 mice were intraperitoneally injected with 0.5 mL normal saline, respectively,serving as control groups. The mice were sacrificed at six months after injection. The expression of anti-double-stranded DNA(ds-DNA)antibody was measured by ELISA. The levels of serum creatinine,serum urea nitrogen and urine protein were detected. Renal tissues were collected for HE staining to evaluate renal pathology. Results:There were no significant differences between WT and S100A9-/- B6 mice on mouse body-weight,spleen weight,kidney-structure,and serum creatitine levels etc. Compared with control B6 mice,pristane treated B6 mice showed increased weight and length of spleen as well as increased levels of serum creatinine,urea nitrogen,proteinuria,anti-ds -DNA antibody and IgG,and the lupus -like changes in the kidney with increased glomerular volume, edema or renal tuble epithelium,and stenosis of lumen. Similar results were observed in pristane-treated S100A9-/- B6 mice,compared with control S100A9-/- B6 mice. However,compared with pristane -treated WT B6 mice,the above symptoms of LN and indexes of serum and urine were mild in pristane-treated S100A9-/-B6 mice. Conclusion:Pristane induces systemic lupus erythematosus in B6 mice and S100A9-/- B6 mice. However,the degree of lesions in mice with S100A9 gene knockout is reduced,suggesting that this gene may have a promoting effect on the pathogenesis of lupus in mice.